Ligand validation:6V2U

P06: Dabrafenib

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HIE_P06_B_801	72%	18%	0.154	0.986	0.91	2.46	2	13	1	0	100%	1
4XV2_P06_A_801	70%	28%	0.158	0.981	1.34	1.44	3	7	2	0	100%	1
5CSW_P06_B_801	37%	20%	0.232	0.936	0.96	2.27	1	11	0	0	100%	1
6HJ2_P06_A_501	18%	2%	0.21	0.803	4.03	2.48	10	9	2	0	100%	0.85
7RIV_P06_A_501	6%	14%	0.382	0.843	1.97	1.82	6	10	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.